Article
Pfizer commits $800,000 to EyeCare America program
New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.
New York-Pfizer Ophthalmics has awarded an $800,000 grant to EyeCare America’s Glaucoma EyeCare Program, which promotes the early detection and treatment of glaucoma by raising awareness of risk factors and providing free access to glaucoma eye exams. The grant will support the program for 2 years.
The public service program of the Foundation of the American Academy of Ophthalmology (AAO) is a nationwide effort through which 7,300 AAO members volunteer to offer glaucoma eye exams and treatment, if necessary, at no cost to eligible uninsured people. The program is designed for U.S. citizens or legal residents who have not had an eye exam in the past 12 months, are at increased risk for glaucoma, and do not receive health care through a managed-care organization or the U.S. Department of Veterans Affairs.
Pfizer Ophthalmics presented the check to EyeCare America at the AAO annual meeting in November.
